Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/25/10 → 8/31/13 |
Funding
- ICON Clinical Research, LLC (A8121014 // A8121014)
- Pfizer Inc. (A8121014 // A8121014)
Protocol A8121014: A Phase 2, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Filibuvir Plus Pegylated Interferon Alfa-2A and Ribavirin in Treatment Naive, HCV Genotype 1 Infected subjects
- Flamm, Steven L (PD/PI)
- Ganger, Daniel R (Co-Investigator)
Project: Research project